Who We've Funded - National Multiple Sclerosis Society

Skip to navigation Skip to content

Who We've Funded

Share

General Fund

We measure success by the progress we make, and we’re thrilled to share that ground-breaking progress. Through individual and collaborative funding, Fast Forward has funded several projects, and we are continually reviewing promising proposals from around the globe. Look at who’s working on the development of new MS treatments – now.

Numerous projects have received funding from the Fast Forward General Fund. 

View General Fund

View General Fund

Collaborative Fund Progress

Fast Forward has formed a 5-year $19 million strategic alliance with EMD Serono/Merck KGaA to speed drug development through the MS pipeline through mutually agreed upon seed-to-early-stage projects.  In the first year of the collaboration, 4 drug development programs in the area of neural repair and protection were selected for funding. Under the terms of the collaboration, EMD Serono/Merck KGaA will have the option to in-license these programs at their completion. A list of the projects is below. 

View Collaborative Fund

View Collaborative Fund

Share

Gary Olson Interview

View this video from Gary Olson at Provid to hear about the impact Fast Forward has had on their work.